Cerner CEO to undergo cancer treatment

Beth Walsh | | Health Exec | EMR/EHR

Cerner co-founder, chairman and CEO, Neal Patterson, is undergoing cancer treatment, according to a filing with the U.S. Securities and Exchange Commission.

Patterson, 66, said he was diagnosed with a soft tissue cancer just after the New Year holiday. “My physician says the type of cancer I have is treatable and curable, and there is no evidence of cancer elsewhere in my body. I feel fine, and I'm surrounded by extraordinarily supportive family, friends, Cerner leaders and Board members. I plan to begin treatment immediately.”

Cerner, founded in 1979 and based in North Kansas City, Mo., is “well-equipped to continue to manage Cerner with our existing leadership structure while I receive treatment." Patterson plans to stay involved in the business, but travel less and attend fewer meetings. His decision to share the news about his condition is " a judgment call," balancing transparency and privacy.

"In reality, it will not be a big change compared to how we run Cerner day-to-day already,” he said.


 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."